Protocol summary

Study aim
Determining the effectiveness of peer-based communication on anxiety in patients with COVID-19
Design
A clinical trial with a control group, with parallel groups, single blind ,on 100 patients
Settings and conduct
The study site is the inpatient wards of patients with Covid-19 in Imam Hossein Hospital in Shahroud. The content of the intervention includes a short educational-supportive video for 10 to 15 minutes, which includes interviews with two patients with COVID-19 who have been discharged from the hospital after recovery. One patient has experience of hospitalization in the ward and next patient has experience of hospitalization in the Intensive Care Unit following COVID-19. During the visual communication with these patients, they are asked to talk about the hospitalization experience, the conditions they had during the hospitalization, the actions they took care of during the hospitalization, the conditions they currently have.
Participants/Inclusion and exclusion criteria
Inclusion criteria - Patients with COVID-19 diagnosed by an infectious specialist by chest CT scan or positive PCR - The patient is in the age range of 18 to 75 years. - Patients who are able to communicate. Exclusion criteria: - Have hearing and speech problems. - The patient has psychological problems based on self-declaration. - Existence of cognitive disorders in elderly patients that affect the possibility of communication.
Intervention groups
.For the intervention group, peer-based communication will be implemented. The content of the intervention includes the presentation of a short educational-supportive video and 24 hours after, the anxiety test questionnaire is completed for the second time in both groups. Patients in the control group receive all routine care programs except peer-to-peer communication.
Main outcome variables
Patients' anxiety

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20200223046586N3
Registration date: 2021-01-11, 1399/10/22
Registration timing: prospective

Last update: 2021-01-11, 1399/10/22
Update count: 0
Registration date
2021-01-11, 1399/10/22
Registrant information
Name
Esmail Shariati
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 23 3234 2000
Email address
shariati@shmu.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2021-01-13, 1399/10/24
Expected recruitment end date
2021-05-13, 1400/02/23
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
The effect of multimedia-based peer support groups on anxiety in patients with COVID-19: a parallel randomized clinical trial
Public title
multimedia-based peer support groups on anxiety in patients
Purpose
Education/Guidance
Inclusion/Exclusion criteria
Inclusion criteria:
Patients with COVID-19 diagnosed by an infectious specialist by chest CT scan or positive PCR The patient is in the age range of 18 to 75 years. Patients who are able to communicate.
Exclusion criteria:
Have hearing and speech problems. The patient has psychological problems based on self-declaration. Existence of cognitive disorders in elderly patients that affect the possibility of communication.
Age
From 18 years old to 75 years old
Gender
Both
Phase
N/A
Groups that have been masked
  • Data analyser
Sample size
Target sample size: 100
Randomization (investigator's opinion)
Randomized
Randomization description
Because patients are gradually admitted to the study and to block the sample size in the two groups, the block method of volume 4 is used. For this purpose, 6 quadruple blocks will be created as follows (AABB, ABAB, ABBA, BBAA, BABA, BAAB). Where A is for the experimental group 1 and B is for the control group. The random assignment will be done in such a way that a random number from 0 to 9 will be created in Excel first. Depending on which block the random number belongs to, the sequence of that block will be used to assign patients to the control and intervention groups. For example, if the random number generated is 6, the first person will be assigned to group B, the second person to group A, the third person to group A, and the fourth person to group B. To reach the calculated sample size, the random number creation will be repeated 25 times. Because in each repetition, the assignment of four patients is determined. It should be noted that if the random number generated is 7, 8, 9 and 0, it will be ignored. In order to prevent contamination of the samples in the control group and blinding during the screening of the film, it was decided to randomly select two separate sections related to the hospitalization of patients with Covid -19, one section for patients in the experimental group and one section for patients in the control group. To do this, 4 envelopes containing (ward 1: experimental) (ward 1: control) (ward2: experimental) (ward 2 control) are prepared and one of these 4 envelopes is randomly selected to randomly determine which of ward is related to the experimental group and which is related to the control group. After each patient is randomly entered into the study and selected based on random blocks, each person will be selected from the ward based on the assigned code. For example, based on ABBA block (experimental group A) and (control group B) for the first patient: the experimental group of ward 1, 2 patients after the control group and ward 2 and again the fourth patient of the experimental group of ward 1 will be selected So that the patients of the two groups are not in contact. The random allocation sequence and the list of quadruple blocks are obtained by the statistics consultant with the help of Excel. Patients who meet the inclusion criteria are registered by the first administrator. Then, based on the prepared blocks, after entering the study, each patient is assigned to the desired group in the order of their entry.
Blinding (investigator's opinion)
Single blinded
Blinding description
Due to the nature of the study, it is not possible to blind the participants and perform the intervention. But demographic information and anxiety measurement questionnaire will be done by a nurse outside the research team at the beginning of the intervention and then after assigning patients to the intervention group and controlling and performing the intervention, the data will be collected by a trained nurse outside the research team. The data is given to a statistician for analysis. The data collector and analyst will not be aware of how individuals are assigned to the groups.
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics committee of Shahroud University of Medical Sciences
Street address
Shahroud University of Medical Sciences and Health Services, Hafte Tir Square, Shahroud, Iran.
City
Shahroud
Province
Semnan
Postal code
۳۶۱۳۷۷۳۹۵۵
Approval date
2020-12-22, 1399/10/02
Ethics committee reference number
IR.SHMU.REC.1399.144

Health conditions studied

1

Description of health condition studied
Covid-19 Disease
ICD-10 code
U07.2
ICD-10 code description
COVID-19, virus not identified

Primary outcomes

1

Description
Zang Anxiety Self-Assessment
Timepoint
Before the intervention and 24 hours after the intervention
Method of measurement
Zang's Self-rating Anxiety Scale (SAS) contains 20 questions on a 4-point Likert scale

Secondary outcomes

empty

Intervention groups

1

Description
Intervention group: After explaining the objectives of the study and obtaining oral and written consent, patients who meet the inclusion criteria will enter the study. Then, the patient completes the patient demographic information questionnaire and the Zang Anxiety Self-Reporting Questionnaire (SAS). Then, based on random quadruple blocks, each patient is randomly assigned a code based on the order of admission to the study, and patients are divided into experimental and control groups based on random codes. Next, for the intervention group, peer-based communication will be implemented. The content of the intervention includes a short educational-supportive video for 10 to 15 minutes, which includes interviews with two patients with COVID-19 who have been discharged from the hospital after recovery. One of them has inpatient experience and the other has inpatient experience following COVID-19. During the visual communication with these patients, they are asked to talk to patients with COVID-19 who are hospitalized and to talk about the hospitalization experience, the conditions they had during their hospitalization, the actions they took during their hospitalization. They noted the current situation and the cases that help patients to strengthen their ability to go through the acute phase of the disease. After presenting a peer-based educational video, if the patient still has questions, the researcher will answer the patients' questions and 24 hours after the re-intervention, the anxiety measurement questionnaire will be completed in both groups. The educational content of a video includes interviews with two recovered patients with Covid-19 disease who have been discharged and have been discharged for at least one month, in which one patient has been admitted to the intensive care unit. The most important interview questions include the following: Tell us about your experience with this disease?Were you anxious during your hospital stay? What did you do to reduce your anxiety? What did or did not do to help you feel better? Explain your condition after discharge from the hospital?. An educational video will be shown to patients via tablet. It should be noted that at each screening of the film, the researcher is with the patient and will answer the patient's questions after the screening of the film. According to the average time of hospitalization of patients, the minimum time will be selected to show the film when 2 to 3 days have passed since the time of hospitalization, which is also the critical condition of the patient and the patient has favorable clinical conditions to watch the educational film.
Category
Behavior

2

Description
Control group: Control group: All routine treatment and care interventions except of multimedia-based peer support groups are performed based on multimedia and the SAS questionnaire is completed by the patient twice (at the beginning of the study and 24 hours after the intervention).
Category
Behavior

Recruitment centers

1

Recruitment center
Name of recruitment center
Imam Hossein Hospital in Shahroud
Full name of responsible person
Esmail Shariati
Street address
Shahroud University of Medical Sciences and Health Services, Hafte Tir Square, Shahroud, Iran.
City
Shahroud
Province
Semnan
Postal code
۳۶۱۳۷۷۳۹۵۵
Phone
+98 23 3239 5054
Email
shariati.esmail@yahoo.com

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Shahroud University of Medical Sciences
Full name of responsible person
Mohammad Hassan Emamian
Street address
Shahroud, 7th of Tir Square, Shahroud University of Medical Sciences and Health Services, Vice Chancellor for Research and Technology
City
Shagroud
Province
Semnan
Postal code
۳۶۱۳۷۷۳۹۵۵
Phone
+98 23 3239 5054
Email
emamian@shmu.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Shahroud University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Shahroud University of Medical Sciences
Full name of responsible person
Hossein Bageri
Position
Assistant Professor, School of Nursing and Midwifery, Shahroud University of Medical Sciences
Latest degree
Ph.D.
Other areas of specialty/work
Nursery
Street address
Shahroud University of Medical Sciences and Health Services, Hafte Tir Square, Shahroud, Iran.
City
Shahroud
Province
Semnan
Postal code
۳۶۱۳۷۷۳۹۵۵
Phone
+98 23 3239 5054
Email
baghe_h1@yahoo.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Shahroud University of Medical Sciences
Full name of responsible person
Esmail Shariati
Position
Master of Critical Care Nursing
Latest degree
Master
Other areas of specialty/work
Nursery
Street address
Shahroud University of Medical Sciences and Health Services, Hafte Tir Square, Shahroud, Iran.
City
Shahroud
Province
Semnan
Postal code
۳۶۱۳۷۷۳۹۵۵
Phone
+98 23 3239 5054
Email
shariati.esmail@yahoo.com

Person responsible for updating data

Contact
Name of organization / entity
Shahroud University of Medical Sciences
Full name of responsible person
Esmail Shariati
Position
Master of Critical Care Nursing
Latest degree
Master
Other areas of specialty/work
Nursery
Street address
Shahroud University of Medical Sciences and Health Services, Hafte Tir Square, Shahroud, Iran.
City
Shahroud
Province
Semnan
Postal code
۳۶۱۳۷۷۳۹۵۵
Phone
+98 23 3239 5054
Email
shariati.esmail@yahoo.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Yes - There is a plan to make this available
Study Protocol
Yes - There is a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Yes - There is a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Not applicable
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Title and more details about the data/document
Part of the demographic information of the patient can be shared after identifying individuals. All information related to measuring the anxiety of patient can be shared after identifying people.
When the data will become available and for how long
Access period starts from June 2021
To whom data/document is available
Researchers / medical students
Under which criteria data/document could be used
Data for correlational studies
From where data/document is obtainable
shariati.esmail@yahoo.com Send message to email above
What processes are involved for a request to access data/document
Clear explanation of the reason for the need to access the data and submit the data after two weeks
Comments
Loading...